Add to Calendar 3/7/2019 8:00:00 AM 3/7/2019 10:00:00 AM Weathering the Storm: BD/Finance Considerations for Economic Downturn Last year Biotech index reached all-time high and the IPO market was red hot. Since then we saw a glimpse of market correction. There is no crystal ball to predict timing of the next economic downturn. But, in the dynamic global economy we should always be ready. How can you improve your company’s chances to endure and even thrive in an economic slowdown? Hear past experiences from Business Development and Finance executives who have “been there, done that” in the past. Leverage our panel’s knowledge regarding the possible moves one could take in a buoyant economy to prepare for the unexpected. Have your questions ready for this interactive forum. MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Chief Financial Officer, Sage Therapeutics
Kimi joined Sage as CFO in 2013, bringing financial and operating strength from her senior management experiences at established, and emerging, life science companies. Prior to joining Sage, Kimi served as Chief Operating Officer, North America, for Santhera Pharmaceuticals, and Vice President of Finance at Cyberkinetics Neurotechnology Systems. Previously, Kimi held roles of increasing responsibility at Millennium Pharmaceuticals and Biogen. She also worked as a business assurance manager at PricewaterhouseCoopers LLP and began her career in chemistry-related positions at various Boston-based companies.